Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Cutting Edge UK Adult Stem Cell Banking Product Oristem now Available Around the World

Published: Tuesday, December 04, 2012
Last Updated: Tuesday, December 04, 2012
Bookmark and Share
Pharmacells Ltd. has announced their stem cell banking service, Oristem® which allows adults of any age to store these vital cells ready to treat diseases that they may get later in life, is now available in 6 countries around the globe.

Since the launch of the product in 2011, we have expanded reach to Hong Kong, China, Lebanon, Pakistan, Ireland and the USA with negotiations underway in several other countries.

To celebrate our global roll out, we have cut our UK price by one third to £1999 including VAT until the end of 2012 only. This is a one-time only offer and subject to a maximum of 4 per household. It is our lowest ever price and will not be repeated.

Until the launch of Oristem®, it has only been possible to store cells using invasive, costly techniques - designed to access cell types that have already “chosen” pathways within the body. The cell type stored using the Oristem® method is significantly less mature, which in scientific terms means that they have much more potential for use within personalised treatments, therapies or pharmaceuticals.

Unlike all other methods, the Oristem® product allows the client to choose when and where their blood is taken. They can then relax in the knowledge that their stem cells have been isolated and stored when they are young and healthy, ready to be returned to them at a time, should it arrive, when they need the cells again to treat a serious illness. Speed to treatment is something that many have never considered but it is a major factor in cell therapy. Several studies have shown that if a donor receives their cells with 48 hours of a major trauma, the efficacy of that cell therapy is greatly improved. That’s why we provide a “stem cell donor card” designed to be carried in the wallet or purse and there to educate medical professionals to the availability of stem cells in the event of a major health incident.

Stem cells are the building blocks of life and are essential for repair of damaged areas of the body. Already stem cells are used in several routine treatments for a wide variety of medical concerns including leukaemia, lymphoma, blood disorders and eye cornea damage. Every year billions are spent globally to push forward this amazing new area of science. Research into many health concerns including Alzheimer's, Parkinson's, Multiple Sclerosis, Diabetes and Stroke heralds the promise of a new dawn within Medical Science.

Athol Haas, CEO of Pharmacells, said “We have worked extremely hard over the last few years to bring this amazing new breakthrough technology to the market. We're proud to be able to use our patented technology to help ensure the future health of our clients. Stem cells are at the forefront of a new wave of medical technologies and our Oristem® product offers, for the first time, a cost effective opportunity for anyone to improve their future health and that of their families”

To deliver Oristem®, Pharmacells commissioned our own clean room facility ensuring that every donor’s sample is processed to the highest possible standards. We hold a full licence from the Human Tissue Authority, further demonstrating our commitment to excellence.

With stem cell research developing quickly and the number of new treatments and therapies expected to rise considerably over the coming years, having quick access to your own healthy cells is a wise health choice. After all, none of us is getting any younger!

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Coronavirus Breakthrough
Protein mutation affects spread and virulence of respiratory virus.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos